VeriMomsalix alba/daphnoides/fragilis/purpurea bark extract é seguro durante a gravidez?
No harmonised reproductive classification in ECHA Annex VI and no SCCS or CIR conclusion identifying reproductive hazard for Salix bark extracts; CIR/SCCS level sources treat salicylates (salicylic acid) separately but willow bark extract itself is not listed as H360/H361. The extract contains salicin (salicylate precursor) which can be systemically converted to salicylic acid, so topical use gives low but measurable exposure depending on concentration and formulation (thus e=1). No credible animal or human reproductive data attributing teratogenicity to willow bark extract were identified in reviewed regulatory sources and peer-reviewed literature.
Related ingredients
Frequently asked questions
- salix alba/daphnoides/fragilis/purpurea bark extract é seguro durante a gravidez?
- No harmonised reproductive classification in ECHA Annex VI and no SCCS or CIR conclusion identifying reproductive hazard for Salix bark extracts; CIR/SCCS level sources treat salicylates (salicylic acid) separately but willow bark extract itself is not listed as H360/H361. The extract contains salicin (salicylate precursor) which can be systemically converted to salicylic acid, so topical use gives low but measurable exposure depending on concentration and formulation (thus e=1). No credible animal or human reproductive data attributing teratogenicity to willow bark extract were identified in reviewed regulatory sources and peer-reviewed literature.
- salix alba/daphnoides/fragilis/purpurea bark extract é seguro durante a amamentação?
- No regulatory harmonised flag or authoritative safety assessment (SCCS/CIR) indicating reproductive or lactation hazards for Salix bark extracts. Theoretical transfer of small amounts of salicylates into circulation is possible from topical use, but expected to be low with typical cosmetic use; evidence for clinically relevant transfer into breast milk from cosmetic topical willow-bark is lacking.
- salix alba/daphnoides/fragilis/purpurea bark extract é seguro para a pele do bebê?
- No evidence that willow bark extract is a reproductive toxicant or teratogen in humans or animals in regulatory reviews. However, infants (0–3 yr) have higher dermal absorption per kg and a less mature barrier: if the extract contains measurable salicylates, exposure is plausibly higher (adult e=1 → infant e incremented to 2). There is limited/no infant-specific safety data for topical willow-bark-containing cosmetics.
- Como o VeriMom pontua salix alba/daphnoides/fragilis/purpurea bark extract?
- O VeriMom pontua salix alba/daphnoides/fragilis/purpurea bark extract em 93/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a salix alba/daphnoides/fragilis/purpurea bark extract na gravidez?
- Veja nossa lista curada de alternativas seguras a salix alba/daphnoides/fragilis/purpurea bark extract com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.